Analysis of preclinical and clinical samples after treatment with a CD37 targeting antibody drug conjugate (AGS67E) support a high level of CD37 expression in NHL. (June 2017) - Doñate, F.; Yang, P.; Morrison, K.; Karki, S.; Aviña, H.; Lackey, J.M.; Sawas, A.; Savage, K.J.; Perez, R.P.; Advani, R.H.; Zain, J.M.; O'Connor, O.A.; et al.